TIME was associated with oncogenic manners in NSCLC patients because KRAS mutations and EGFR L858R mutation play a critical role in inflammatory response and immune resistance in tumor microenvironment (Jin et al., 2020). Here, EGFR is linked to non-small cell lung carcinoma.